Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis

BACKGROUND: Lung adenocarcinoma (LUAD) is the most common pathological type of lung cancer. At present, most patients with LUAD are diagnosed at an advanced stage, and the prognosis of advanced LUAD is poor. Hence, we aimed to identify novel biomarkers for the diagnosis and treatment of early stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yingji, Jin, Longyu, Jiang, Zhibin, Liu, Suo, Feng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085413/
https://www.ncbi.nlm.nih.gov/pubmed/33937050
http://dx.doi.org/10.3389/fonc.2021.644426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085413/
https://www.ncbi.nlm.nih.gov/pubmed/33937050
http://dx.doi.org/10.3389/fonc.2021.644426

Ejemplares similares